Samuel C. Blackman, Chief Medical Officer at Day One Biopharmaceuticals, Inc. (DAWN), sold 1,229 shares at $16.00 ($20K) on 2023-06-05, disclosed to the SEC on 2023-06-07.
Scheduled sale ($20k) by Chief Medical Officer under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| Filing → |
| DAWN | SELL | 2024-11-12 | $751K | — | Filing → |
| DAWN | SELL | 2024-11-08 | $361K | — | Filing → |
| DAWN | SELL | 2024-11-04 | $8K | — | Filing → |